CME Quote, Financials, Valuation and Earnings

Coinbase Global has a net margin of 57.61% compared to CME Group's net margin of 6.26%. CME Group's return on equity of 12.57% beat Coinbase Global's return on equity of 20.89%.

CME Group has a consensus price target of $242.38, signalling upside risk potential of 1.21%. On the other hand Coinbase Global has an analysts' consensus of $292.28 which suggests that it could grow by 4.53%. Given that Coinbase Global has higher upside potential than CME Group, analysts believe Coinbase Global is more attractive than CME Group.

CME Group has a beta of 0.563, which suggesting that the stock is 43.731% less volatile than S&P 500. In comparison Coinbase Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

CME Group has a quarterly dividend of $1.15 per share corresponding to a yield of 4.11%. Coinbase Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CME Group pays 100.29% of its earnings as a dividend. Coinbase Global pays out -- of its earnings as a dividend.

CME Group quarterly revenues are $1.6B, which are larger than Coinbase Global quarterly revenues of $1.2B. CME Group's net income of $912.8M is higher than Coinbase Global's net income of $75.5M. Notably, CME Group's price-to-earnings ratio is 25.18x while Coinbase Global's PE ratio is 47.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 14.26x versus 14.88x for Coinbase Global. Usually stocks with elevated PS ratios are considered overvalued.

FactSet Research Systems has a net margin of 57.61% compared to CME Group's net margin of 26.38%. CME Group's return on equity of 12.57% beat FactSet Research Systems's return on equity of 28.97%.

CME Group has a consensus price target of $242.38, signalling upside risk potential of 1.21%. On the other hand FactSet Research Systems has an analysts' consensus of $471.11 which suggests that it could fall by -4.12%. Given that CME Group has higher upside potential than FactSet Research Systems, analysts believe CME Group is more attractive than FactSet Research Systems.

CME Group has a beta of 0.563, which suggesting that the stock is 43.731% less volatile than S&P 500. In comparison FactSet Research Systems has a beta of 0.763, suggesting its less volatile than the S&P 500 by 23.653%.

CME Group has a quarterly dividend of $1.15 per share corresponding to a yield of 4.11%. FactSet Research Systems offers a yield of 0.83% to investors and pays a quarterly dividend of $1.04 per share. CME Group pays 100.29% of its earnings as a dividend. FactSet Research Systems pays out 28.05% of its earnings as a dividend. FactSet Research Systems's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are larger than FactSet Research Systems quarterly revenues of $568.7M. CME Group's net income of $912.8M is higher than FactSet Research Systems's net income of $150M. Notably, CME Group's price-to-earnings ratio is 25.18x while FactSet Research Systems's PE ratio is 35.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 14.26x versus 8.50x for FactSet Research Systems. Usually stocks with elevated PS ratios are considered overvalued.

Intercontinental Exchange has a net margin of 57.61% compared to CME Group's net margin of 21.66%. CME Group's return on equity of 12.57% beat Intercontinental Exchange's return on equity of 9.23%.

CME Group has a consensus price target of $242.38, signalling upside risk potential of 1.21%. On the other hand Intercontinental Exchange has an analysts' consensus of $183.50 which suggests that it could grow by 21.96%. Given that Intercontinental Exchange has higher upside potential than CME Group, analysts believe Intercontinental Exchange is more attractive than CME Group.

CME Group has a beta of 0.563, which suggesting that the stock is 43.731% less volatile than S&P 500. In comparison Intercontinental Exchange has a beta of 1.082, suggesting its more volatile than the S&P 500 by 8.177%.

CME Group has a quarterly dividend of $1.15 per share corresponding to a yield of 4.11%. Intercontinental Exchange offers a yield of 1.2% to investors and pays a quarterly dividend of $0.45 per share. CME Group pays 100.29% of its earnings as a dividend. Intercontinental Exchange pays out 40.33% of its earnings as a dividend. Intercontinental Exchange's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Intercontinental Exchange quarterly revenues of $3B. CME Group's net income of $912.8M is higher than Intercontinental Exchange's net income of $657M. Notably, CME Group's price-to-earnings ratio is 25.18x while Intercontinental Exchange's PE ratio is 35.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 14.26x versus 7.59x for Intercontinental Exchange. Usually stocks with elevated PS ratios are considered overvalued.

Nasdaq has a net margin of 57.61% compared to CME Group's net margin of 16.09%. CME Group's return on equity of 12.57% beat Nasdaq's return on equity of 9.57%.

CME Group has a consensus price target of $242.38, signalling upside risk potential of 1.21%. On the other hand Nasdaq has an analysts' consensus of $84.17 which suggests that it could grow by 6.65%. Given that Nasdaq has higher upside potential than CME Group, analysts believe Nasdaq is more attractive than CME Group.

CME Group has a beta of 0.563, which suggesting that the stock is 43.731% less volatile than S&P 500. In comparison Nasdaq has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.25%.

CME Group has a quarterly dividend of $1.15 per share corresponding to a yield of 4.11%. Nasdaq offers a yield of 1.19% to investors and pays a quarterly dividend of $0.24 per share. CME Group pays 100.29% of its earnings as a dividend. Nasdaq pays out 41.64% of its earnings as a dividend. Nasdaq's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Nasdaq quarterly revenues of $1.9B. CME Group's net income of $912.8M is higher than Nasdaq's net income of $306M. Notably, CME Group's price-to-earnings ratio is 25.18x while Nasdaq's PE ratio is 47.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 14.26x versus 6.43x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.